GSA Capital Partners’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-663,704
| Closed | -$757K | – | 2050 |
|
|
2026
Q1 | $757K | Buy |
663,704
+42,376
| +7% | +$52.2K | 0.05% | 631 |
|
|
2025
Q4 | $783K | Buy |
+621,328
| New | +$865K | 0.07% | 505 |
|
|
2025
Q2 | – | Sell |
-1,343,701
| Closed | -$2.23M | – | 2038 |
|
|
2025
Q1 | $2.23M | Buy |
1,343,701
+261,495
| +24% | +$431K | 0.2% | 46 |
|
|
2024
Q4 | $1.59M | Buy |
+1,082,206
| New | +$1.65M | 0.12% | 160 |
|
|
2023
Q1 | – | Sell |
-87,738
| Closed | -$110K | – | 1811 |
|
|
2022
Q4 | $110K | Buy |
+87,738
| New | +$138K | 0.01% | 1296 |
|
|
2022
Q1 | – | Sell |
-65,604
| Closed | -$316K | – | 1716 |
|
|
2021
Q4 | $316K | Buy |
+65,604
| New | +$266K | 0.04% | 892 |
|
|
2021
Q2 | – | Sell |
-13,892
| Closed | -$60K | – | 1522 |
|
|
2021
Q1 | $60K | Sell |
13,892
-13,095
| -49% | -$62.6K | 0.01% | 1025 |
|
|
2020
Q4 | $107K | Sell |
26,987
-185,326
| -87% | -$774K | 0.02% | 1091 |
|
|
2020
Q3 | $783K | Buy |
212,313
+185,037
| +678% | +$781K | 0.13% | 182 |
|
|
2020
Q2 | $93K | Sell |
27,276
-346,120
| -93% | -$775K | 0.05% | 491 |
|
|
2020
Q1 | $500K | Buy |
373,396
+298,834
| +401% | +$468K | 0.13% | 173 |
|
|
2019
Q4 | $110K | Buy |
74,562
+43,309
| +139% | +$72.5K | 0.01% | 1333 |
|
|
2019
Q3 | $65K | Sell |
31,253
-115,935
| -79% | -$237K | 0.01% | 1303 |
|
|
2019
Q2 | $359K | Sell |
147,188
-21,985
| -13% | -$48K | 0.04% | 880 |
|
|
2019
Q1 | $442K | Buy |
+169,173
| New | +$512K | 0.04% | 765 |
|
|
2018
Q4 | – | Sell |
-317,500
| Closed | -$1.1M | – | 1634 |
|
|
2018
Q3 | $1.1M | Buy |
317,500
+46,422
| +17% | +$246K | 0.06% | 627 |
|
|
2018
Q2 | $1.27M | Buy |
+271,078
| New | +$1.03M | 0.06% | 586 |
|
|
2016
Q3 | – | Sell |
-18,800
| Closed | -$176K | – | 1905 |
|
|
2016
Q2 | $176K | Sell |
18,800
-5,300
| -22% | -$53.8K | 0.01% | 1606 |
|
|
2016
Q1 | $250K | Sell |
24,100
-96,301
| -80% | -$880K | 0.02% | 1392 |
|
|
2015
Q4 | $1.21M | Sell |
120,401
-183,435
| -60% | -$1.84M | 0.06% | 562 |
|
|
2015
Q3 | $2.56M | Buy |
303,836
+155,106
| +104% | +$2.05M | 0.13% | 170 |
|
|
2015
Q2 | $2.39M | Buy |
148,730
+41,230
| +38% | +$641K | 0.09% | 264 |
|
|
2015
Q1 | $1.52M | Buy |
+107,500
| New | +$1.4M | 0.06% | 533 |
|
|
2014
Q4 | – | Sell |
-31,692
| Closed | -$270K | – | 1845 |
|
|
2014
Q3 | $270K | Buy |
31,692
+15,534
| +96% | +$137K | 0.01% | 1328 |
|
|
2014
Q2 | $143K | Buy |
+16,158
| New | +$141K | 0.01% | 1687 |
|
|
2014
Q1 | – | Sell |
-125,099
| Closed | -$1.06M | – | 1741 |
|
|
2013
Q4 | $1.06M | Buy |
125,099
+85,015
| +212% | +$859K | 0.08% | 326 |
|
|
2013
Q3 | $353K | Buy |
+40,084
| New | +$322K | 0.03% | 1029 |
|
Other funds holding OPK
RCMNY
WCM
GSA Capital Partners's OPK Position: Q2 2026 in Review
GSA Capital Partners sold out of Opko Health (OPK) in Q2 2026, closing a stake of 663,704 shares — an estimated $757K sold.
GSA Capital Partners first reported a position in OPK in Q3 2013 and held it in 27 quarters. The position peaked at $2.56M in Q3 2015. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- GSA Capital Partners reported no remaining Opko Health position as of Q2 2026 after selling out during the quarter.
- GSA Capital Partners sold 663,704 Opko Health shares in Q2 2026, an estimated $757K.
- GSA Capital Partners first reported a position in Opko Health in Q3 2013 and held it in 27 quarters.
- GSA Capital Partners's Opko Health position peaked at $2.56M in Q3 2015.
- 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.